Wednesday, December 07, 2016 9:30:59 AM
I believe that CTCA www.cancercenter.com/ has taken possession of all the goods and the AVAX patents.
Perhaps CTCA might be interested to go on Nasdaq, using shares of AVAX ...
---------------------------------------------
What do you think about: no progression study of O-vax and restarted study about M-vax?
Estimated Enrollment: 387
Study Start Date: July 2016
Estimated Study Completion Date: January 2021
Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)
https://clinicaltrials.gov/ct2/show/NCT00477906?term=avax&rank=1
Unfortunately: This study is not yet open for participant recruitment
I sent an email to Dr. Henry but without reply...
CONTACTS:
Contact: Henry E Schea 215 241-9760 ext 1302 henry@avax-tech.com
.
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM